In East Moline, Illinois, long winters and limited specialist access can make weight management harder than it should be. Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk since 2021. Weight Method offers a separate option: licensed Illinois providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for East Moline starts at $199/month — medication, provider evaluation, ongoing care, and shipping included.
FDA-approved Wegovy prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · East Moline is already seeing results
Wegovy in East Moline, IL: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Wegovy to patients in East Moline from $199/month with virtual consultations and direct-to-door shipping.
For many people in East Moline, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Semaglutide addresses hormonal drivers involved in body weight regulation. Wegovy® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk, approved in 2021 for Chronic weight management. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The program is priced at $199/month, including the evaluation, the medication, ongoing care, and home delivery to East Moline.
In the suburbs of East Moline, getting to a weight loss specialist often means a drive to a medical center and a long wait for an appointment. Weight Method eliminates that obstacle: consult with a licensed Illinois provider from your home, receive your compounded Semaglutide prescription (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved), and have it shipped directly at $199/month.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Illinois and start Wegovy from $199/month.
Get Started NowFree consultation. No commitment.